New investigations into retatrutide, a dual activator for GLP-1 and GIP receptors, are demonstrating significant effects in treating weight gain and type 2 condition. Animal data suggest a novel mechanism contributing https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/